We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12.8B
AUM Growth
+$1.36B
Cap. Flow
+$773M
Cap. Flow %
6.06%
Top 10 Hldgs %
12.57%
Holding
2,812
New
294
Increased
855
Reduced
703
Closed
290

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$28.3M
2
HAL icon
Halliburton
HAL
+$24.2M
3
EA icon
Electronic Arts
EA
+$23.9M
4
ICON
Iconix Brand Group, Inc.
ICON
+$23.7M
5
HELE icon
Helen of Troy
HELE
+$20.4M

Sector Composition

Rank Sector Weight
1 Technology 14.92%
2 Healthcare 14.07%
3 Industrials 12.64%
4 Financials 10.64%
5 Consumer Discretionary 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
W icon
1801
Wayfair
W
$11.1B
$19K ﹤0.01%
+1,000
New +$24K
DF
1802
DELISTED
Dean Foods Company
DF
$19K ﹤0.01%
1,000
EMES
1803
DELISTED
Emerge Energy Services LP
EMES
$19K ﹤0.01%
355
+135
+61% +$10.1K
KATE
1804
DELISTED
Kate Spade & Company
KATE
$19K ﹤0.01%
600
-117
-16% -$3.34K
AMCR
1805
DELISTED
AMCOR LTD ADR
AMCR
$19K ﹤0.01%
+438
New +$19K
CHT icon
1806
Chunghwa Telecom
CHT
$33.2B
$18K ﹤0.01%
+624
New +$18.7K
DB icon
1807
Deutsche Bank
DB
$66.3B
$18K ﹤0.01%
+691
New +$19.4K
MET.PRA icon
1808
MetLife Inc Floating Rate Series A
MET.PRA
$504M
$18K ﹤0.01%
+800
New +$18.9K
NRC icon
1809
NRC Health Common Stock
NRC
$474M
$18K ﹤0.01%
1,300
NRP icon
1810
Natural Resource Partners
NRP
$1.3B
$18K ﹤0.01%
200
PBYI icon
1811
Puma Biotechnology
PBYI
$406M
$18K ﹤0.01%
+100
New +$22.2K
PSEC icon
1812
Prospect Capital
PSEC
$1.06B
$18K ﹤0.01%
2,276
PXH icon
1813
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.9B
$18K ﹤0.01%
1,000
SHG icon
1814
Shinhan Financial Group
SHG
$33.6B
$18K ﹤0.01%
+451
New +$20K
CAMP
1815
DELISTED
CalAmp Corp.
CAMP
$18K ﹤0.01%
44
-555
-93% -$237K
LTS
1816
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$18K ﹤0.01%
+4,600
New +$18.2K
TFCF
1817
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$18K ﹤0.01%
500
TLOG
1818
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$18K ﹤0.01%
3,925
ESNC
1819
DELISTED
EnSync Inc
ESNC
$18K ﹤0.01%
36,070
AFG icon
1820
American Financial Group
AFG
$11.9B
$17K ﹤0.01%
305
-210
-41% -$12.5K
ASH icon
1821
Ashland
ASH
$3.04B
$17K ﹤0.01%
292
-19,420
-99% -$1.05M
FXC icon
1822
Invesco CurrencyShares Canadian Dollar Trust
FXC
$69.2M
$17K ﹤0.01%
200
GEG icon
1823
Great Elm Group
GEG
$68.4M
$17K ﹤0.01%
1,417
-1,710
-55% -$29.2K
HCSG icon
1824
Healthcare Services Group
HCSG
$1.56B
$17K ﹤0.01%
575
IRBT
1825
DELISTED
iRobot
IRBT
$17K ﹤0.01%
500

Similar funds

Glenmede Trust's Q4 2014 Portfolio in Review

As of Q4 2014, Glenmede Trust held 2,812 positions worth $12.8B, up 12% from $11.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust deployed $773M of net new capital in Q4 2014, opening 294 new positions and adding to 855 existing holdings. Its largest new stake was Portland General Electric: 447,386 shares worth $16.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was eBay, an estimated $18.8M trimmed.

  • Glenmede Trust's largest Q4 2014 buy was Portland General Electric: 447,386 shares worth $16.9M.
  • Glenmede Trust added most to Labcorp in Q4 2014, an estimated $28.3M increase.
  • Glenmede Trust's biggest Q4 2014 reduction was eBay, cutting an estimated $18.8M.
  • Glenmede Trust fully exited SAPIENT CORP in Q4 2014, selling an estimated $16.9M.
  • Glenmede Trust's ten largest holdings make up 13% of its $12.8B portfolio in Q4 2014.
  • Glenmede Trust opened 294 new positions and closed 290 in Q4 2014.
  • Glenmede Trust's portfolio value rose 12% quarter-over-quarter to $12.8B.

Based on Glenmede Trust's 13F filing for Q4 2014, filed 6 Feb 2015.